Knocking down Wnt9a mRNA levels increases cellular proliferation

Yang Xiang1, Ge Lin, Qianjun Zhang

  • 1Institute of Human Reproduction and Stem Cell Engineering, Central South University, 88 Xiangya Road, Changsha, Hunan, 410078, China. xiangyang397@hotmail.com

Insights

Researchers used RNA interference (RNAi) to investigate human Wnt9a in breast cancer cells. Lowering Wnt9a expression promoted cell proliferation, while over-expression inhibited it, suggesting Wnt9a

Area of Science:

  • Molecular biology
  • Cell biology
  • Cancer research

Background:

  • Wnt signaling proteins are involved in tissue development and are implicated in various cancers.
  • RNA interference (RNAi) is a mechanism to inhibit gene expression using small double-stranded RNA.
  • Human Wnt9a's role in breast cancer proliferation requires further elucidation.

Purpose of the Study:

  • To construct siRNA expression vectors for human Wnt9a.
  • To investigate the effect of Wnt9a expression levels on MCF-7 breast cancer cell proliferation.

Main Methods:

  • Construction of siRNA expression vectors using pAVU6+27 vectors.
  • Synthesis and in situ hybridization of anti-Wnt9a hairpin siRNA inserts.
  • Flow cytometry analysis to assess cell proliferation rates.

Main Results:

  • Transfection with anti-Wnt9a siRNA significantly reduced Wnt9a signals in cells.
  • Reduced Wnt9a expression in MCF-7 cells promoted cellular proliferation.
  • Over-expression of Wnt9a inhibited proliferation in MCF-7 cells.

Conclusions:

  • Human Wnt9a expression levels influence the proliferation rate of MCF-7 breast cancer cells.
  • Wnt9a plays a role in regulating cellular proliferation within breast cancer contexts.
  • RNAi is an effective method for modulating Wnt9a expression and studying its cellular effects.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...